Pathway Summary for UBA7

Overview

UBA7 (Ubiquitin-like Modifier Activating Enzyme 7) is the E1 activating enzyme for ISG15, a ubiquitin-like protein induced by interferon signaling. UBA7 initiates ISGylation, a post-translational modification system that conjugates ISG15 to target proteins, playing critical roles in antiviral immunity and immune regulation.

Core Pathways

ISGylation Cascade

UBA7 initiates ISG15 conjugation through:
- ATP-dependent ISG15 activation
- Thioester bond formation with ISG15
- Transfer to UBE2L6 (E2 enzyme)
- Ultimate conjugation by HERC5/TRIM25 (E3 ligases)

Interferon Response Pathway

UBA7 is a key effector of type I interferon signaling:
- Induced by IFN-α/β through JAK-STAT
- ISGylates viral and host proteins
- Restricts viral replication
- Modulates immune responses

Pathway Diagram

graph TD A[Type I IFN] --> B[JAK-STAT] B --> C[ISG15 Expression] B --> D[UBA7: E1 Enzyme] C --> D E[ATP] --> D D -->|activation| F[ISG15~UBA7] F --> G[UBE2L6: E2] G --> H[HERC5/TRIM25: E3] H --> I[Target ISGylation] I --> J[Antiviral Response] I --> K[Immune Modulation] L[USP18: DeISGylase] --|removes ISG15| I M[Viral Proteins] --> I N[Host Proteins] --> I style D fill:#f9f,stroke:#333,stroke-width:2px style I fill:#ffd,stroke:#333,stroke-width:1px

Upstream Regulation

Downstream Effects

Clinical Significance

Molecular Mechanism

Integration with Immunity